Q3 FY2025 · ended Jun 30, 2025 · Revenue $0 · Filed Aug 10, 2026
Veru Inc. (VERU) files with the SEC under industry code 2834, Pharmaceutical Preparations. Free cash flow was -$5.5 million. As of Jun 30, 2026 it held $23.9 million in cash and investments and $2.7 million in total debt.
Revenue
$0
Net income
$-6.99M
+4.7% vs year-ago quarter
Operating cash flow
$-5.47M
+0.3% vs year-ago quarter
Free cash flow
$-5.47M
+0.3% vs year-ago quarter
EPS
—
Dividend per share
None
Shares outstanding
17.05M
+16.4% vs year-ago quarter
Net cash
$21.20M
Q3 FY2026
Operating margin
-140.4%
Q4 FY2024
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- VERU (Nasdaq)
- Fiscal year ends
- September 30
- Incorporated in
- WI
- Headquarters
- Miami, FL
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 863894
- Former names
- FEMALE HEALTH CO (until Aug 1, 2017)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q3 FY2026 Jun 30, 2026 |
Q2 FY2026 Mar 31, 2026 |
Q1 FY2026 Dec 31, 2025 |
Q4 FY2025 Sep 30, 2025 |
Q3 FY2025 Jun 30, 2025 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | $0 |
| Operating income | -$7.7M | -$7.2M | -$5.4M | $1.2M | -$7.5M |
| Net income | -$7.0M | -$2.7M | -$5.3M | $1.5M | -$7.3M |
| Operating cash flow | -$5.5M | -$8.9M | -$6.2M | -$5.5M | -$5.5M |
| Free cash flow | -$5.5M | -$8.9M | -$6.2M | -$5.5M | -$5.5M |
| Total assets | $37.0M | $43.1M | $47.6M | $29.8M | $27.3M |
| Total liabilities | $8.7M | $8.3M | $10.4M | $11.5M | $12.0M |
| Stockholders' equity | $28.4M | $34.8M | $37.1M | $18.3M | $15.3M |
| Cash and investments | $23.9M | $27.6M | $33.0M | $15.8M | $15.0M |
| Total debt | $2.7M | $2.8M | $3.0M | $3.1M | $3.3M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Other events
|
Sep 8, 2026 | Sep 8, 2026 |
| 10-Q | Quarterly report | Aug 10, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2026 | Aug 10, 2026 |
| 8-K |
Current report
Material agreement
|
Jul 2, 2026 | Jul 2, 2026 |
| 8-K |
Current report
Other events
|
Jun 4, 2026 | Jun 2, 2026 |
| 10-Q | Quarterly report | May 13, 2026 | Mar 31, 2026 |
All 1000 Veru Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.